Phase II studies on docetaxel alone every third week, or weekly in combination with gemcitabine in patients with primary locally advanced, metastatic, or recurrent esophageal cancer

By Albertsson M.   Johansson B.   Friesland S.   Kadar L.   Letocha H.   Frykholm G.   Wagenius G.  

Medical Oncology, Vol. 24, Iss. 4, 2007-12 ,pp. : 407-412

Humana Press, Inc

Access to resources Recommend Favorite

Weekly chemotherapy with carboplatin, docetaxel and irinotecan in advanced non-small-cell-lung cancer - a phase II study

By Pectasides D.   Visvikis A.   Kouloubinis A.   Glotsos J.   Bountouroglou N.   Karvounis N.   Ziras N.   Athanassiou A.  

European Journal of Cancer, Vol. 38, Iss. 9, 2002-06 ,pp. : 1194-1200

Elsevier

Access to resources Recommend Favorite

Carboplatin with weekly docetaxel and ifosfamide in advanced head and neck cancers: a phase I Brown University Oncology Group dose escalation study (HN-93)

By Rathore Ritesh   Birnbaum Ariel   Rathore Bharti   DiPetrillo Thomas   Kennedy Teresa   Ready Neal  

Cancer Chemotherapy and Pharmacology, Vol. 66, Iss. 6, 2010-11 ,pp. : 1013-1017

Springer Publishing Company

Access to resources Recommend Favorite

Carboplatin as a Radiation Sensitizer in Locally Advanced Cervical Cancer: A Pilot Study

By Muderspach L.I.   Curtin J.P.   Roman L.D.   Gebhardt J.A.   Klement V.   Qian D.   Morrow C.P.   Felix J.C.   Formenti S.C.   Muggia F.M.  

Gynecologic Oncology, Vol. 65, Iss. 2, 1997-05 ,pp. : 336-342

Elsevier

Access to resources Recommend Favorite

First-Line Chemotherapy with Weekly Paclitaxel and Carboplatin for Advanced Ovarian Cancer: A Phase I Study

By Sehouli J.   Stengel D.   Elling D.   Ortmann O.   Blohmer J.   Riess H.   Lichtenegger W.  

Gynecologic Oncology, Vol. 85, Iss. 2, 2002-05 ,pp. : 321-326

Academic Press

Access to resources Recommend Favorite